Loading ...

Error:
Message:
Pharma Partnering Meetings since 1995. Made in Europe for the World.

Delegates' Comments

"…many have attended 20 or 30 times or more…"
Dr. Norbert Rau
"…have achieved a number of successful deal outcomes…"
Paul Phull
"…four times as much for half the price…"
Anke Rau and Dr. Norbert Rau
"euroPLX is sometimes tough and intense…"
Sebastien Sanial and Malgorzata Derewianka
"…a very efficient way to meet in one-to-one meetings…"
Dr. Peter Komnick and Dr. Silke Behne
"We are Platinum Sponsors of euroPLX 49 Istanbul, because…"
Rich DiCicco
"We became a returning attendee as we've never left empty-handed…"
Kees Trommelen
"…get focused on the business...just business!"
Dragan Lutz and Mario Vlasic
"I have successfully used the euroPLX meetings for licensing-in and licensing-out…"
Dr. Satyendra Kumar
"…meet your business partners at the well organized events…"
Peter van Hoogstraten and Paul C. Borghouts
"…a highly effective and pleasant way to meet…"
Ronald Kriek and Wouter Hanegraaf
"…interact with so many companies…"
Simona Aganovic and Guy Clark
"We get value for our money…"
Vilas Nagare and Sundeep V. Bambolkar
"It’s the best partnering event…"
Jinang Parekh and Vijay Agarwal
"…the only partnering conference that covers all aspects of business development…"
Dr. Hubert Ridolphi and Dr. Gerrit Hagens
"…no better event than euroPLX to enlarge your network in the
pharmaceutical business…"
Gilbert Adatte
"...good place to expand your international network..."
Ramon Brusco
"…we wouldn’t do that if there were no results!"
Patrick Tichy
"…one of the few events which attracts a cross section of attendees from all pharmaceutical sectors…"
Daniel Jones
"…the best time and cost effective way to meet new partners."
Nuray Acar and Mutlu Topal
"There is no end to new challenges at euroPLX"
Ruud Koolen
"…a basis for excellent business."
Ana Paula Branco and José Roberto Pereira
"euroPLX is the most cost-effective and time-saving way…"
David Zubeldía
"…euroPLX is the perfect place…"
Gustavo Samojeden and Hernán Bouzada
"…good opportunity for meeting with many relevant players…"
Dietmar Jannaschk and Gemma Mogas
"…a tremendous opportunity to meet new partners…"
Marc Alvarez
"…efficient and fruitful one-to-one discussions…"
Sylvie Fondanayche
"We are not aware of any other event where you can meet so many interesting partners…"
Holger and Kai Schleenhain
"I rate euroPLX very high…"
Reynhardt Van As
"euroPLX is the best pharma meeting…"
Santiago, Mar, and Josémaria Calzada
"…very good opportunity to meet existing and new business partners…"
Agnes Olszanowski and Dr. Marian Takac
"I never leave euroPLX empty-handed."
Wendell Clayton
"…the best possible way to contact a large number of people…" Shala Fardaei and Ineke Braat
"It was in this forum that we forged some of our major alliances…" Nimit Jhaveri and Biplab Kar
"…we have made a lot of money on euroPLX deals…"
Rich DiCicco
"…an ideal opportunity to meet…"
Andreas Wagner & Michel Blanc
"…extremely time and cost efficient way to make new business contacts…"
Wolfgang Bäurle
"euroPLX is the most efficient event I know…"
Patsy Carney
"…the most efficient of the Business Development forums…"
Roland Brown
"…a tremendous opportunity to network intensely…"
Elzbieta Weston & Jacek Plucienniczak

Sponsors for Recent Meeting


Bronze Sponsor
Panacea Pharma Projects Ltd


Media Sponsors

Pharmalicensing
currentPartnering
GenericsWeb
Bvents
Generics Bulletin
OTC Bulletin
Pharmatching
EUBIO
B3C newswire


Yet Another Productive Partnering Conference

euroPLX 48 Lisbon

A fully booked partnering conference with more than 4,000 pre-scheduled one-on-one meetings.

Click to view registered companies

Business development delegates of 170 companies from 36 countries convened in Cascais, near Lisbon, Portugal for over 4,000 targeted business negotiations around pharma and life science product developments, licensing, marketing or similar issues.

An average of almost 24 pre-scheduled one-to-one appointments per attending company on 5 and 6 March 2012 supports the reputation of euroPLX Meetings as being more productive than most other partnering conferences.

euroPLX 48 Lisbon

Registered Companies

The country names designate the places where the attending delegates are based, not necessarily the respective company's headquarters!

Alpha-medical d.o.o. (Croatia)
Auxilium Cura Innovatio (Sweden)
BioClin B.V. (Netherlands)
BMG Pharma (Italy)
Cipla Ltd (India)
Interquim, S.A. (Spain)
Ixal Ltd (United Kingdom)
Kela Pharma NV (Belgium)
Vivatech (France)


Cancellations

Aspen Pharma EU
Farma-Tek Pharmaceuticals
Fresenius Medical Care (Ireland) Ltd
Niche Generics Ltd.
Panacea Biotec Ltd
Vifor Pharma - Swiss Licensing

Contact us

phone: +49 (6222) 9807-0
e-mail: please go to contact form

euroPLX Business Developer

Receive the euroPLX newsletter!
read more

Dynamic Partnering Focus


Hourly updated partnering interests areas of registrants
General Interest Areas
Products for (click to view)
Hospital
percent
71%
Practitioner
percent
75%
Consumer
percent
71%

Development Stage (click to view)
Preclinical
percent
7%
Phase I/II
percent
10%
Phase III
percent
29%
Approved
percent
97%

IP status (click to view)
Patented
percent
53%
Biosimilar
percent
13%
Generic
percent
85%

Product category (click to view)
Prescription
percent
91%
Over-the-Counter
percent
62%
Food supplements
percent
33%

Supporting items (click to view)
Drug delivery technology
percent
23%
Medical devices
percent
33%
Diagnostics
percent
4%

Services (click to view)
R&D services
percent
17%
Clinical research services
percent
6%
Regulatory services
percent
16%
Contract manufacture
percent
34%
API supply
percent
19%
Finished product supply
percent
69%

Therapeutic Interest Areas
Cardiovascular
percent
75%
Immunology
percent
46%
Oncology
percent
67%
CNS, Neurology
percent
75%
Gastroenterology
percent
74%
Urology
percent
63%
Female/Male health
percent
58%
Pain
percent
74%
Respiratory
percent
67%
Dermatology
percent
60%
Musculo-skeletal
percent
61%
Metabolism/Endocrinology
percent
53%
Ophthalmology
percent
43%
Other therapeutic areas
percent
48%


Copyright by RauCon 1996-2012